Panavance Therapeutics
  • Our Science
    • Pipeline
    • About Misetionamide
    • Mechanism of Action
  • About
    • About Persevere
    • Leadership
    • Advisors
    • Contact Persevere
  • Resources
    • Publications
    • Press Releases

Let’s engage.

The effect of GP-2250 on cultured virus-negative Merkel cell carcinoma cells: preliminary results

November 11, 2023 / 0 Minute Read

persevere therapeutics

  • Our Science
  • About
  • Resources
  • LinkedIn

+1.610.922.1910

Copyright © 2026 Persevere Therapeutics Inc.